Bayer fined $16.2M in price-fixing probe

Bayer was fined $16.2 million for fixing the prices of aspirin and other over-the-counter meds in Germany; the government alleged that a local Bayer subsidiary made illegal rebate deals with more than 21,000 pharmacies. Bayer denied the allegations, saying it agreed to the fine to avoid a long legal fight. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.